MedPath

Comparison of prophylactic effect of venlafaxine and topiramate in patients with chronic migraine : An open label randomized controlled trial

Phase 2
Recruiting
Conditions
Migraine.
Migraine
Registration Number
IRCT20120227009157N8
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Patients who met the ICHD-3 criteria
Age 20-55 years

Exclusion Criteria

Taking migraine prophylactic drugs in the last 4 weeks
Suffeing from renal, cardiovascular and liver diseases.
Having major depression, bipolar disorder and psychosis
Having hypertension or ocular hypertension
Pregnancy or lactation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath